These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25258527)

  • 1. Nanopharmaceuticals (part 1): products on the market.
    Weissig V; Pettinger TK; Murdock N
    Int J Nanomedicine; 2014; 9():4357-73. PubMed ID: 25258527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanopharmaceuticals (part 2): products in the pipeline.
    Weissig V; Guzman-Villanueva D
    Int J Nanomedicine; 2015; 10():1245-57. PubMed ID: 25709446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
    Farjadian F; Ghasemi A; Gohari O; Roointan A; Karimi M; Hamblin MR
    Nanomedicine (Lond); 2019 Jan; 14(1):93-126. PubMed ID: 30451076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds.
    Rivera Gil P; Hühn D; del Mercato LL; Sasse D; Parak WJ
    Pharmacol Res; 2010 Aug; 62(2):115-25. PubMed ID: 20097288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicines accessible in the market for clinical interventions.
    Gadekar V; Borade Y; Kannaujia S; Rajpoot K; Anup N; Tambe V; Kalia K; Tekade RK
    J Control Release; 2021 Feb; 330():372-397. PubMed ID: 33370576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second world conference on nanomedicine and drug delivery.
    Ninan N; Thomas S; George A; Sebastian M
    Ther Deliv; 2011 Jun; 2(6):711-5. PubMed ID: 22822503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation aspects of nanopharmaceuticals and nanotechnology I Introduction, biopharmaceutical aspects.
    Viktor F; Emese B; Geza J; Istvan A
    Acta Pharm Hung; 2016; 86(2):43-52. PubMed ID: 29873962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory.
    Caputo F; Mehn D; Clogston JD; Rösslein M; Prina-Mello A; Borgos SE; Gioria S; Calzolai L
    J Chromatogr A; 2021 Jan; 1635():461767. PubMed ID: 33310281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patenting of nanopharmaceuticals in drug delivery: no small issue.
    du Toit LC; Pillay V; Choonara YE; Pillay S; Harilall SL
    Recent Pat Drug Deliv Formul; 2007; 1(2):131-42. PubMed ID: 19075880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular polymer bottlebrushes in nanomedicine: therapeutic and diagnostic applications.
    Müllner M
    Chem Commun (Camb); 2022 May; 58(38):5683-5716. PubMed ID: 35445672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patented and Approval Scenario of Nanopharmaceuticals with Relevancy to Biomedical Application, Manufacturing Procedure and Safety Aspects.
    Agarwal V; Bajpai M; Sharma A
    Recent Pat Drug Deliv Formul; 2018; 12(1):40-52. PubMed ID: 29303083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.
    Petrovic S; Bita B; Barbinta-Patrascu ME
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of Green Synthesis and Potential Pharmaceutical Applications of Nanoparticles as Targeted Drug Delivery System in Biomedicines.
    Mittal S; Chakole CM; Sharma A; Pandey J; Chauhan MK
    Drug Res (Stuttg); 2022 Jun; 72(5):274-283. PubMed ID: 35562101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Nanomedicines and Nano-Similars: Recent Advances in Regulatory Landscape.
    Paliwal R; Kumar P; Chaurasiya A; Kenwat R; Katke S; Paliwal SR
    Curr Pharm Des; 2022; 28(2):165-177. PubMed ID: 34781869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine.
    Fang C; Zhang M
    J Control Release; 2010 Aug; 146(1):2-5. PubMed ID: 20493220
    [No Abstract]   [Full Text] [Related]  

  • 20. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
    Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.